MPM BIOVENTURES 2018, L.P. has an estimated net worth of $226 Million. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., iTeos Therapeutics, Inc., Aktis Oncology, Inc., and Entrada Therapeutics, Inc..

2020 was MPM BIOVENTURES 2018, L.P.'s most active year for acquiring shares with 21 total transactions. MPM BIOVENTURES 2018, L.P.'s most active month to acquire stocks was the month of June. 2021 was MPM BIOVENTURES 2018, L.P.'s most active year for disposing of shares, totalling 72 transactions. MPM BIOVENTURES 2018, L.P.'s most active month to dispose stocks was the month of August. 2026 saw MPM BIOVENTURES 2018, L.P. paying a total of $20,029,986.00 for 9,918,355 shares, this is the most they've acquired in one year. In 2025 MPM BIOVENTURES 2018, L.P. cashed out on 630,191 shares for a total of $5,079,339.46, their largest year based on trade value.